LUMIS for Colorectal Cancer
Advanced colorectal cancer (recurrent or T4 tumors)
Phase 2Active
Key Facts
About OncoLux
OncoLux is pioneering a 'See and Treat' platform for intraoperative cancer care, merging advanced photonics and AI to visualize and immediately treat residual disease. Its LUMIS™ platform is designed for use in minimally invasive and robotic surgeries, with a Phase II trial ongoing in colorectal cancer and a planned First-in-Human study in lung cancer for 2027. The company aims to reduce cancer recurrence by ensuring more complete tumor removal during the initial surgical intervention.
View full company profile